BR112016024235A2 - pharmaceutical compositions comprising antibacterial agents - Google Patents

pharmaceutical compositions comprising antibacterial agents

Info

Publication number
BR112016024235A2
BR112016024235A2 BR112016024235A BR112016024235A BR112016024235A2 BR 112016024235 A2 BR112016024235 A2 BR 112016024235A2 BR 112016024235 A BR112016024235 A BR 112016024235A BR 112016024235 A BR112016024235 A BR 112016024235A BR 112016024235 A2 BR112016024235 A2 BR 112016024235A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
antibacterial agents
pharmaceutically acceptable
acceptable derivative
aztreonam
Prior art date
Application number
BR112016024235A
Other languages
Portuguese (pt)
Inventor
Narendra Khande Hemant
UMARKAR Kushal
Vithalbhai Patel Mahesh
Ratnakar JOSHI Prashant
Bhagwat Sachin
Rameshwar PALWE Snehal
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of BR112016024235A2 publication Critical patent/BR112016024235A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

a presente invenção refere-se a composições farmacêuticas compreendendo aztreonam ou um derivado farmaceuticamente aceitável e um composto da fórmula (i) ou um estereoisômero ou um derivado farmaceuticamente aceitável do mesmo.The present invention relates to pharmaceutical compositions comprising aztreonam or a pharmaceutically acceptable derivative and a compound of formula (I) or a stereoisomer or a pharmaceutically acceptable derivative thereof.

BR112016024235A 2014-04-18 2015-04-17 pharmaceutical compositions comprising antibacterial agents BR112016024235A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1407MU2014 2014-04-18
PCT/IB2015/052814 WO2015159265A1 (en) 2014-04-18 2015-04-17 Pharmaceutical compositions comprising antibacterial agents

Publications (1)

Publication Number Publication Date
BR112016024235A2 true BR112016024235A2 (en) 2017-08-15

Family

ID=53276202

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016024235A BR112016024235A2 (en) 2014-04-18 2015-04-17 pharmaceutical compositions comprising antibacterial agents

Country Status (8)

Country Link
US (1) US10857138B2 (en)
EP (1) EP3131583A1 (en)
JP (1) JP6678116B2 (en)
KR (1) KR102173632B1 (en)
CN (1) CN107980000A (en)
BR (1) BR112016024235A2 (en)
MX (1) MX2016013431A (en)
WO (1) WO2015159265A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10417727B2 (en) * 2016-09-26 2019-09-17 Uber Technologies, Inc. Network system to determine accelerators for selection of a service
EP3301094A1 (en) * 2016-09-30 2018-04-04 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
KR102354697B1 (en) * 2017-03-02 2022-01-21 욱크하르트 리미티드 Heterocyclic derivatives as antibacterial compounds
US10085999B1 (en) * 2017-05-10 2018-10-02 Arixa Pharmaceuticals, Inc. Beta-lactamase inhibitors and uses thereof
WO2019093450A1 (en) * 2017-11-10 2019-05-16 塩野義製薬株式会社 Diazabicyclooctane derivative
CN111670187B (en) 2018-01-25 2021-04-16 苏州信诺维医药科技有限公司 Beta-lactamase inhibitor and use thereof
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US342553A (en) * 1886-05-25 Induction-coil
US2874279A (en) 1952-08-06 1959-02-17 Itt Pulse selector circuit
BR112013028813B1 (en) * 2011-08-27 2020-10-20 Wockhardt Limited 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and pharmaceutical compositions comprising them
BR112013032974A2 (en) * 2011-08-30 2016-09-06 Wockhardt Ltd "1,6-diazabicyclo [3,2,1] -octan-7-one derivatives, their uses, and pharmaceutical compositions".
WO2013038330A1 (en) * 2011-09-13 2013-03-21 Wockhardt Limited Nitrogen containing compounds and their use
US8796257B2 (en) * 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
US8916709B2 (en) * 2012-03-30 2014-12-23 Cubist Pharmaceuticals, Inc. 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
US8962844B2 (en) * 2012-03-30 2015-02-24 Cubist Pharmaceuticals, Inc. 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
MX366948B (en) 2012-05-30 2019-07-30 Meiji Seika Pharma Co Ltd NOVEL ß-LACTAMASE INHIBITOR AND METHOD FOR PRODUCING SAME.
US9433613B2 (en) 2013-01-14 2016-09-06 Wockhardt Limited Compositions and methods for treating bacterial infections

Also Published As

Publication number Publication date
US20170035740A1 (en) 2017-02-09
EP3131583A1 (en) 2017-02-22
JP2017511368A (en) 2017-04-20
CN107980000A (en) 2018-05-01
WO2015159265A1 (en) 2015-10-22
KR102173632B1 (en) 2020-11-03
MX2016013431A (en) 2017-04-13
US10857138B2 (en) 2020-12-08
JP6678116B2 (en) 2020-04-08
KR20160138305A (en) 2016-12-02

Similar Documents

Publication Publication Date Title
TW201613911A (en) Heterocyclic compounds and uses thereof
BR112018003026A2 (en) compositions comprising a pi3k inhibitor and an hdac inhibitor
BR112016024235A2 (en) pharmaceutical compositions comprising antibacterial agents
UA116648C2 (en) FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES
CL2015002767A1 (en) Therapeutic compounds and compositions
MY197698A (en) Oxysterols and methods of use thereof
BR112018070123A2 (en) oxiesterós and methods of use thereof
BR112016011755A2 (en) derived from urea or pharmacologically acceptable salt thereof
BR112016021012A2 (en) pharmaceutical compositions of therapeutically active compounds.
BR112018072539A2 (en) increased administration epinephrine compositions
MX2020010839A (en) Aripiprazole formulations having increased injection speeds.
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
BR112018074985A2 (en) antibacterial compositions
PH12017502319A1 (en) Injectable pharmaceutical formulations of lefamulin
CL2015003431A1 (en) Pyridone derivatives for the treatment of viral infections and additional diseases
BR112016028948A2 (en) ? biphasic composition?
DOP2016000325A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITION AND ITS USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
BR112016024236A2 (en) pharmaceutical compositions comprising antibacterial agents
NZ719215A (en) Pharmaceutical compositions comprising antibacterial agents
MX2016005539A (en) Pharmaceutical compositions comprising antibacterial agents.
MX2016005160A (en) Pharmaceutical compositions comprising antibacterial agents.
IN2014MU00859A (en)
BR112016028081A2 (en) NEW COMPOUNDS AS ANTITUBERCULAR AGENTS
IN2013MU03421A (en)
BR112016022439A2 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING CEFEPIM OR SULBACTAM

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B350 Update of information on the portal [chapter 15.35 patent gazette]